HCG share price has declined by 30% in the past three months and 38% since our downgrade in February, 2018 and the recent correction offers another opportunity to take a positive view on the stock.
The Food and Drug Administration (FDA) has approved hCG injections to treat specific medical conditions. In females assigned at birth (FAABs), they can help treat infertility. In males assigned at ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback